DAA1099 |
Schlafen Family Member 11 |
Molecular |
pons |
Human |
SLFN11 |
Increase DNA Methylation |
|
DAA1083 |
Dipeptidyl-peptidase 8 |
Molecular |
pons |
Human |
DPP8 |
Increase DNA Methylation |
|
DAA1095 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
pons |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA1087 |
Rhomboid Domain Containing 1 |
Molecular |
pons |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA1115 |
Growth Arrest-specific 2 Like 3 |
Molecular |
pons |
Human |
GAS2L3 |
Increase DNA Methylation |
|
DAA1111 |
Dickkopf-like 1 |
Molecular |
pons |
Human |
DKKL1 |
Increase DNA Methylation |
|
DAA1079 |
Pipecolic Acid Oxidase |
Molecular |
pons |
Human |
PIPOX |
Increase DNA Methylation |
|
DAA1103 |
Myogenic Differentiation 1 |
Molecular |
pons |
Human |
MYOD1 |
Increase DNA Methylation |
|
DAA1981 |
Selective increase in oxidative damage and decrease in antioxidant function during aging in the substantia nigra |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA722 |
Accumulation of neuromelanin in dopaminergic nigral neurons |
Physiological |
substantia nigra |
Human |
— |
— |
|
DAA743 |
Sensitivity of HPA axis is impaired |
Physiological |
pituitary gland, adrenal gland, hypothalamus |
Human |
— |
— |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|
DAA2180 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
58.9% Increase Gene Expression Level |
|
DAA2178 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
33.1% Increase Gene Expression Level |
|
DAA2179 |
Clusterin increases with age |
Molecular |
hippocampus |
Human |
CLU |
41.7% Increase Gene Expression Level |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
Molecular |
hippocampus |
Human |
CXCL5 |
64.9% Increase Gene Expression Level |
|
DAA2277 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
hippocampus |
Human |
FCGR2A |
316.4% Increase Gene Expression Level |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
hippocampus |
Human |
CXCL16 |
100.6% Increase Gene Expression Level |
|
DAA2170 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
hippocampus |
Human |
C1QB |
391.4% Increase Gene Expression Level |
|
DAA2141 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
hippocampus |
Human |
FCGR1B |
434.2% Increase Gene Expression Level |
|
DAA2160 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
hippocampus |
Human |
FCGR3B |
647.0% Increase Gene Expression Level |
|
DAA2278 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
hippocampus |
Human |
FCGR3B |
80.8% Increase Gene Expression Level |
|
DAA2296 |
Chemokine (C-C motif) receptor 1 increases with age |
Molecular |
hippocampus |
Human |
CCR1 |
182.5% Increase Gene Expression Level |
|
DAA2297 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
hippocampus |
Human |
CCR1 |
93.8% Increase Gene Expression Level |
|
DAA2150 |
complement component 4B increases with age |
Molecular |
hippocampus |
Human |
C4B |
466.1% Increase Gene Expression Level |
|